ARDT Stock Analysis: Buy, Sell, or Hold?

ARDT - Ardent Health, Inc.

SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC
$10.99
0.51 (4.87%) ▲
5d: +0.73%
30d: +5.47%
90d: +19.33%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 04, 2026 0d

Get Alerted When ARDT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
â„šī¸ NEUTRAL: ARDT is fairly priced but lacks strong directional signals. At 6.9% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$13.42
Based on 8.5% avg growth
INTRINSIC VALUE TODAY
$8.33
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.3x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: ARDT is currently trading at $10.99, which is considered slightly high relative to its 30-day fair value range of $10.38 to $11.19. From a valuation perspective, the stock is trading at a premium (Forward PE: 8.9) compared to its historical average (7.3). At these levels, the market is pricing in 6.9% annual earnings growth.

Technical Outlook: Technically, ARDT is in a uptrend. Immediate support is located at $10.35, while resistance sits at $11.72. The stock is showing strong short-term momentum, up 4.9% recently.

Market Sentiment: ARDT scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.68 (+15.4%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $10.38 - $11.19
Company Quality Score 45/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 48.6%

All Signals

  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+4.9%)
  • BULLISH: Trading below Wall St target ($12.68)
  • BULLISH: Expecting earnings turnaround to 6.9% growth with -1.4% revenue growth
  • WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $10.38 - $11.19
Current vs Trading Range SLIGHTLY HIGH

Support & Resistance Levels

Support Level $10.35
Resistance Level $11.73
Current Trend Uptrend
Technical data as of Aug 21, 2026

Fundamental Context

Forward P/E (Next Year Est.) 8.95
Wall Street Target $12.68 (+15.4%)
Revenue Growth (YoY) -1.4%
Earnings Growth (YoY) -77.1%
Profit Margin 1.2%
Valuation Premium vs History +6.9% premium
PE vs Historical 9.0 vs 7.3 STRETCHED
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +6.9% (market-implied from PE analysis)
1-Year Target $11.75 (+7%)
2-Year Target $12.56 (+14%)
3-Year Target $13.43 (+22%)
3-Yr Target (if PE normalizes) (PE: 9→7) PE COMPRESSION $10.95 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 20.1, Growth: 12.9%) $35.49 (+223%)
Base: (SPY PE: 8.9, Growth: 12.9%) $15.82 (+44%)
Bear: (PE: 7.3, Growth: 12.9%) $12.91 (+17%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (19x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 19.41 | Current EPS (TTM): $0.54
Bull Case $23.06 (+110%)
Analyst growth 100.0%, PE expands to 21.4
Base Case $20.96 (+91%)
Market implied 100.0%, PE stable at 19.4
Bear Case $7.13 (-35%)
Severe decline -20.0%, PE contracts to 16.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 23, 2026 1:03 AM ET
Data refreshes hourly during market hours. Next update: 2:03 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for ARDT.

Create Free Account

Already have an account? Log In

Top Rated Medical Care Facilities Stocks

Top-rated stocks in Medical Care Facilities by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
THC
Tenet Healthcare Corporaâ€Ļ
STRONG BUY
22 analysts
$282 37 SELL
HCA
HCA Healthcare, Inc.
BUY
25 analysts
$455 44 HOLD
CMPS
Compass Pathways Plc
STRONG BUY
11 analysts
$24 47 HOLD
EHC
Encompass Health Corp
STRONG BUY
12 analysts
$148 42 HOLD
ADUS
Addus HomeCare Corporatiâ€Ļ
STRONG BUY
11 analysts
$135 54 HOLD

More Analysis for ARDT

ARDT Technical Chart ARDT Price Prediction ARDT Earnings Date ARDT Investment Advisor ARDT Fair Price Analyzer ARDT Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals